SUMMARY fl-glucuronidase deficiency is an extremely rare disorder which is known to have a considerable phenotypic variation. A survey of the clinical findings in 19 previously reported patients with mucopolysaccharidosis VII is presented together with the results of clinical and biochemical studies in two further patients. Because a similar clinical picture is present in a heterozygotic sister it is doubted whether all signs and symptoms can be attributed to the P-glucuronidase deficiency.
Since the first description of abnormal mucopolysacchariduria in a girl with splenohepatomegaly, normal. The thoracolumbar spine showed a scoliosis to the left. A slight hirsutism was present.
Further general and neurological examination showed no abnormalities.
Family history A second sister, born in 1952, turned out to be a carrier of MPS VII. She had a non-progressive severely retarded psychomotor development and was institutionalised at the age of 17 years. Since she was 15, she has been suffering from sporadic tonic clonic seizures, which are being controlled with medication. Physical examination showed a severely mentally retarded patient with a height of 1 50m and a microcephaly (head circumference <2-5th percentile). Her facies was coarse. Further general and neurological examination showed no abnormalities. All the remaining family members, three siblings included, are in good health and the family history gives no evidence of epilepsy, mental retardation or other relevant particularities.
Once the diagnosis was established in the institutionalised members of the family, the parents refused all further investigations. The healthy family members refused blood analysis for carrier detection.
Radiological studies Radiographs of skull, chest, ribs, spine, hands and feet of case I as well as computed tomography scanning were normal. Radiological studies of case 2 and the sister were not performed.
Electrophysiological studies
The EEG of case I showed a low-voltage fast background activity with bilateral but predominantly right-sided temporal sharp theta paroxysms. Later recordings showed diffuse spike to wave complexes. The EEG of case 2 demonstrated a normal pattern in the posterior region but too much diffuse fast activity. Bilateral paroxysmal irritation existed in the frontal regions. The EEG of the sister showed a low voltage fast pattern. Routine 
Results

Biochemical analysis
The deficiency of,-glucuronidase has been established in leucocytes, plasma and hair roots of both patients ( normal. Ultrastructural studies of the granulocytes in the peripheral blood of case I revealed that the vacuoles contained light-floccular material (fig 2) . Lymphocytes were normal. Discussion A considerable phenotypic variation is known to exist in MPS VII. It is, however, possible to recognise similar features in the majority of cases. They correspond more or less to the symptoms of the patient described by Sly et al,3 symptoms which include a coarse facies, splenohepatomegaly, a gibbus deformity, diastasis recti, umbilical and inguinal herniae, metatarsus adductus, recurrent respiratory infections, and growth and development retardation. Later reports revealed the existence of cases with sometimes only minor clinical symptoms which were usually diagnosed at adolescence.5 ' Sewell et 16 Our patients differ in several respects from the others reported to date. They are the oldest patients described in the literature. The more typical signs of MPS VII are absent (table 1) . Both patients as well as their heterozygous sister are suffering from epilepsy and severe mental retardation. Epilepsy has not been mentioned before in cases of MPS VII, and severe mental retardation is only seen in combination with other symptoms characteristic of this disorder. These facts and the presence of similar features in the heterozygous sister suggest that epilepsy and mental retardation in our patients are not related to MPS VII but to a concomitant disorder. Since the patients show only mild signs of MPS VII, they should in our opinion be classified under group III.
Our patients have a somewhat higher residual P-glucuronidase activity (3-4%) compared with previously described patients, in whom the specific activities of this enzyme for serum and leucocytes are generally reduced to 0 1-2% of the mean control values.3 7 9 16 We had the opportunity to perform a hair root analysis in case 1. Such a procedure has not been reported before in cases of MPS VII. It turned out that the deficiency actually can be established in hair roots. A similar level of residual f,-glucuronidase activity was found in leucocytes and in hair roots. The biochemical studies in the patients reported by us are remarkable because no glycosaminoglycans could be detected in their urine by routine procedures; this is in contrast to the findings of all patients with MPS VII described in the literature. The reports mention the excretion of several different glycosaminoglycans. This may be due to variation in the methods of laboratory investigations. The patient reported by Sly et al3 excreted chondroitin sulphate, which was also reported by other authors as the principal excreted storage product.5 10 14 16 On the other hand, the patients described by Gehler et al, 6 Beaudet et al,7 Pfeiffer et al8 and Teyssier et al'2 excreted predominantly dermatan and heparan sulphates.
Although no elevated amounts of storage products could be found in the urine of our two patients, cellular morphology clearly provided evidence of a storage disease. Light microscopy showed cytoplasmic granu-mucopolysaccharidosis VII. 
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